190 related articles for article (PubMed ID: 18599739)
1. Leukocyte-derived hepatic lipase increases HDL and decreases en face aortic atherosclerosis in LDLr-/- mice expressing CETP.
Hime NJ; Black AS; Bulgrien JJ; Curtiss LK
J Lipid Res; 2008 Oct; 49(10):2113-23. PubMed ID: 18599739
[TBL] [Abstract][Full Text] [Related]
2. Bone marrow-derived HL mitigates bone marrow-derived CETP-mediated decreases in HDL in mice globally deficient in HL and the LDLr.
Hime NJ; Black AS; Bonnet DJ; Curtiss LK
J Lipid Res; 2014 Sep; 55(9):1864-75. PubMed ID: 24818611
[TBL] [Abstract][Full Text] [Related]
3. Important role for bone marrow-derived cholesteryl ester transfer protein in lipoprotein cholesterol redistribution and atherosclerotic lesion development in LDL receptor knockout mice.
Van Eck M; Ye D; Hildebrand RB; Kar Kruijt J; de Haan W; Hoekstra M; Rensen PC; Ehnholm C; Jauhiainen M; Van Berkel TJ
Circ Res; 2007 Mar; 100(5):678-85. PubMed ID: 17293475
[TBL] [Abstract][Full Text] [Related]
4. Lipolytic and ligand-binding functions of hepatic lipase protect against atherosclerosis in LDL receptor-deficient mice.
Freeman L; Amar MJ; Shamburek R; Paigen B; Brewer HB; Santamarina-Fojo S; González-Navarro H
J Lipid Res; 2007 Jan; 48(1):104-13. PubMed ID: 17071916
[TBL] [Abstract][Full Text] [Related]
5. Synthetic farnesoid X receptor agonists induce high-density lipoprotein-mediated transhepatic cholesterol efflux in mice and monkeys and prevent atherosclerosis in cholesteryl ester transfer protein transgenic low-density lipoprotein receptor (-/-) mice.
Hambruch E; Miyazaki-Anzai S; Hahn U; Matysik S; Boettcher A; Perović-Ottstadt S; Schlüter T; Kinzel O; Krol HD; Deuschle U; Burnet M; Levi M; Schmitz G; Miyazaki M; Kremoser C
J Pharmacol Exp Ther; 2012 Dec; 343(3):556-67. PubMed ID: 22918042
[TBL] [Abstract][Full Text] [Related]
6. Thyroid hormone increases plasma cholesteryl ester transfer protein activity and plasma high-density lipoprotein removal rate in transgenic mice.
Berti JA; Amaral ME; Boschero AC; Nunes VS; Harada LM; Castilho LN; Oliveira HC
Metabolism; 2001 May; 50(5):530-6. PubMed ID: 11319713
[TBL] [Abstract][Full Text] [Related]
7. ApoE-dependent modulation of HDL and atherosclerosis by G2A in LDL receptor-deficient mice independent of bone marrow-derived cells.
Parks BW; Srivastava R; Yu S; Kabarowski JH
Arterioscler Thromb Vasc Biol; 2009 Apr; 29(4):539-47. PubMed ID: 19164809
[TBL] [Abstract][Full Text] [Related]
8. Cholesteryl ester transfer protein decreases high-density lipoprotein and severely aggravates atherosclerosis in APOE*3-Leiden mice.
Westerterp M; van der Hoogt CC; de Haan W; Offerman EH; Dallinga-Thie GM; Jukema JW; Havekes LM; Rensen PC
Arterioscler Thromb Vasc Biol; 2006 Nov; 26(11):2552-9. PubMed ID: 16946130
[TBL] [Abstract][Full Text] [Related]
9. Deficiency of Cholesteryl Ester Transfer Protein Protects Against Atherosclerosis in Rabbits.
Zhang J; Niimi M; Yang D; Liang J; Xu J; Kimura T; Mathew AV; Guo Y; Fan Y; Zhu T; Song J; Ackermann R; Koike Y; Schwendeman A; Lai L; Pennathur S; Garcia-Barrio M; Fan J; Chen YE
Arterioscler Thromb Vasc Biol; 2017 Jun; 37(6):1068-1075. PubMed ID: 28428219
[TBL] [Abstract][Full Text] [Related]
10. Increased HDL cholesterol and apoA-I in humans and mice treated with a novel SR-BI inhibitor.
Masson D; Koseki M; Ishibashi M; Larson CJ; Miller SG; King BD; Tall AR
Arterioscler Thromb Vasc Biol; 2009 Dec; 29(12):2054-60. PubMed ID: 19815817
[TBL] [Abstract][Full Text] [Related]
11. Cholesteryl ester transfer protein (CETP) expression protects against diet induced atherosclerosis in SR-BI deficient mice.
Harder C; Lau P; Meng A; Whitman SC; McPherson R
Arterioscler Thromb Vasc Biol; 2007 Apr; 27(4):858-64. PubMed ID: 17272756
[TBL] [Abstract][Full Text] [Related]
12. Procollagen C-endopeptidase Enhancer Protein 2 (PCPE2) Reduces Atherosclerosis in Mice by Enhancing Scavenger Receptor Class B1 (SR-BI)-mediated High-density Lipoprotein (HDL)-Cholesteryl Ester Uptake.
Pollard RD; Blesso CN; Zabalawi M; Fulp B; Gerelus M; Zhu X; Lyons EW; Nuradin N; Francone OL; Li XA; Sahoo D; Thomas MJ; Sorci-Thomas MG
J Biol Chem; 2015 Jun; 290(25):15496-15511. PubMed ID: 25947382
[TBL] [Abstract][Full Text] [Related]
13. Niacin increases HDL by reducing hepatic expression and plasma levels of cholesteryl ester transfer protein in APOE*3Leiden.CETP mice.
van der Hoorn JW; de Haan W; Berbée JF; Havekes LM; Jukema JW; Rensen PC; Princen HM
Arterioscler Thromb Vasc Biol; 2008 Nov; 28(11):2016-22. PubMed ID: 18669886
[TBL] [Abstract][Full Text] [Related]
14. Cholesteryl ester transfer protein (CETP) expression enhances HDL cholesteryl ester liver delivery, which is independent of scavenger receptor BI, LDL receptor related protein and possibly LDL receptor.
Zhou H; Li Z; Silver DL; Jiang XC
Biochim Biophys Acta; 2006 Dec; 1761(12):1482-8. PubMed ID: 17055779
[TBL] [Abstract][Full Text] [Related]
15. Hematopoietic arginase 1 deficiency results in decreased leukocytosis and increased foam cell formation but does not affect atherosclerosis.
Ren B; Van Kampen E; Van Berkel TJ; Cruickshank SM; Van Eck M
Atherosclerosis; 2017 Jan; 256():35-46. PubMed ID: 27998825
[TBL] [Abstract][Full Text] [Related]
16. Remodeling of HDL by CETP in vivo and by CETP and hepatic lipase in vitro results in enhanced uptake of HDL CE by cells expressing scavenger receptor B-I.
Collet X; Tall AR; Serajuddin H; Guendouzi K; Royer L; Oliveira H; Barbaras R; Jiang XC; Francone OL
J Lipid Res; 1999 Jul; 40(7):1185-93. PubMed ID: 10393203
[TBL] [Abstract][Full Text] [Related]
17. Epistatic effect of cholesteryl ester transfer protein and hepatic lipase on serum high-density lipoprotein cholesterol levels.
Isaacs A; Aulchenko YS; Hofman A; Sijbrands EJ; Sayed-Tabatabaei FA; Klungel OH; Maitland-van der Zee AH; Stricker BH; Oostra BA; Witteman JC; van Duijn CM
J Clin Endocrinol Metab; 2007 Jul; 92(7):2680-7. PubMed ID: 17440012
[TBL] [Abstract][Full Text] [Related]
18. Overexpression of Cholesteryl Ester Transfer Protein Increases Macrophage-Derived Foam Cell Accumulation in Atherosclerotic Lesions of Transgenic Rabbits.
Gao S; Wang X; Cheng D; Li J; Li L; Ran L; Zhao S; Fan J; Liu E
Mediators Inflamm; 2017; 2017():3824276. PubMed ID: 29317793
[TBL] [Abstract][Full Text] [Related]
19. Contribution of hepatic lipase, lipoprotein lipase, and cholesteryl ester transfer protein to LDL and HDL heterogeneity in healthy women.
Carr MC; Ayyobi AF; Murdoch SJ; Deeb SS; Brunzell JD
Arterioscler Thromb Vasc Biol; 2002 Apr; 22(4):667-73. PubMed ID: 11950708
[TBL] [Abstract][Full Text] [Related]
20. LDL Receptor Regulates the Reverse Transport of Macrophage-Derived Unesterified Cholesterol via Concerted Action of the HDL-LDL Axis: Insight From Mouse Models.
Cedó L; Metso J; Santos D; García-León A; Plana N; Sabate-Soler S; Rotllan N; Rivas-Urbina A; Méndez-Lara KA; Tondo M; Girona J; Julve J; Pallarès V; Benitez-Amaro A; Llorente-Cortes V; Pérez A; Gómez-Coronado D; Ruotsalainen AK; Levonen AL; Sanchez-Quesada JL; Masana L; Kovanen PT; Jauhiainen M; Lee-Rueckert M; Blanco-Vaca F; Escolà-Gil JC
Circ Res; 2020 Aug; 127(6):778-792. PubMed ID: 32495699
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
